Isa Hezekiah, Okocha Emmanuel, Adegoke Samuel Ademola, Nnebe-Agumadu Uche, Kuliya-Gwarzo Aisha, Sopekan Alayo, Ofakunrin Akinyemi Olugbenga, Ugwu Ngozi, Hassan Abdul-Aziz, Ohiaeri Chinatu, Madu Anazoeze, Diaku-Akinwumi Ijeoma, Ekwem Lilian, Dogara Livingstone Gayus, Okoh Dorothy, Jasini James, Girei Ahmed, Ekwere Timothy, Okolo Angela, Kangiwa Umar, Lawson Juliet, Chianumba Reuben, Brown Biobele, Akinola Norah, Nwegbu Maxwell, Nnodu Obiageli
Centre of Excellence for Sickle Cell Research and Training, University of Abuja (CESRTA) Federal Capital Territory (FCT), Abuja, Nigeria.
Department of Haematology and Blood Transfusion, University of Abuja, Abuja, Nigeria.
Front Genet. 2023 Feb 3;14:1052444. doi: 10.3389/fgene.2023.1052444. eCollection 2023.
Sickle cell disease (SCD) continues to pose physical and psychosocial burdens to patients, caregivers and health workers. Stakeholder engagement in the processes of policy making and implementation is increasingly becoming the cornerstone of best practices in healthcare. To engage stakeholders with a view to assessing the knowledge of SCD; ascertain the challenges associated with accessibility and affordability of healthcare services; improve the quality of care, and thereby effect behavioral change through increasing attendance and follow-up of patients in the clinics. A Stakeholders' Engagement meeting organized by the Sickle Pan Africa Research Consortium Nigeria Network (SPARC-NEt) was attended by patients, caregivers and members of patient support groups, healthcare providers and management/policymakers. The engagement was through PowerPoint presentations, structured questionnaires and an interactive session. The structured questionnaire assessed the knowledge of stakeholders about SCD; the quality of healthcare services; challenges with access and affordability; and SCD-related government policies. Three hundred and twelve stakeholders attended the engagement meeting. Of the 133 that participated in the study, medical workers were the most represented. The majority had good knowledge of what causes SCD (96.2%) and the best place to get help during SCD crisis (98.5%). However, knowledge of the specific preventive measures of SCD and its crisis was not optimal. In terms of the role of community engagement and education, only about one-quarter of the study participants, 34 (25.6%) knew about their positive role in reducing the prevalence of SCD and alleviating SCD crises. Challenges identified include inadequate healthcare personnel and facilities, delay in obtaining laboratory results, long waiting time in the clinic, poor communication, absence of holistic consultation, uncoordinated healthcare services, high cost of care, ignorance, non-prioritization of SCD by government, lack of multisectoral collaboration and partnership with NGOs and international organizations. Strategies proffered to improve healthcare services include, community/stakeholder engagement and health education, sickle cell daycare services, access to a willing and dedicated multidisciplinary workforce, collaboration with support groups and government policies and programs. There is need for regular stakeholder engagement to improve access to healthcare services for SCD patients in Nigeria.
镰状细胞病(SCD)继续给患者、护理人员和医护人员带来身体和心理社会负担。利益相关者参与政策制定和实施过程正日益成为医疗保健最佳实践的基石。为了让利益相关者参与进来,以评估他们对SCD的了解;确定与医疗服务可及性和可负担性相关的挑战;提高护理质量,从而通过增加患者在诊所的就诊率和随访率来实现行为改变。由尼日利亚镰状细胞泛非研究联盟网络(SPARC-NEt)组织的一次利益相关者参与会议,患者、护理人员、患者支持团体成员、医疗服务提供者以及管理人员/政策制定者参加了会议。参与方式包括PowerPoint演示、结构化问卷和互动环节。结构化问卷评估了利益相关者对SCD的了解、医疗服务质量、可及性和可负担性方面的挑战以及与SCD相关的政府政策。312名利益相关者参加了这次参与会议。在参与研究的133人中,医疗工作者占比最大。大多数人对SCD的病因(96.2%)以及SCD危机期间获得帮助的最佳地点(98.5%)有很好的了解。然而,对SCD的具体预防措施及其危机的了解并不理想。在社区参与和教育的作用方面,只有约四分之一的研究参与者,即34人(25.6%)知道其在降低SCD患病率和缓解SCD危机方面的积极作用。所确定的挑战包括医疗人员和设施不足、获取实验室结果延迟、在诊所等待时间长、沟通不畅、缺乏全面会诊、医疗服务不协调、护理成本高、无知、政府未将SCD列为优先事项、缺乏多部门合作以及与非政府组织和国际组织的伙伴关系。为改善医疗服务提出的策略包括社区/利益相关者参与和健康教育、镰状细胞日托服务、获得愿意且专注的多学科工作人员、与支持团体合作以及政府政策和项目。有必要定期让利益相关者参与,以改善尼日利亚SCD患者获得医疗服务的情况。